Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda Institute of Tropical Medicine University of Antwerp
SETTING: In 2005, in response to the increasing prevalence of rifampicin-resistant tuberculosis (RR -TB) and poor treatment outcomes, Rwanda initiated the programmatic management of RR-TB, including expanded access to systematic rifampicin drug suscep-tibility testing (DST) and standardised treatment.
OBJECTIVE: To describe trends in diagnostic and treatment delays and estimate their effect on RR-TB mortality.
DESIGN: ...